15256 Federal Register / Vol. 87, No. 52 / Thursday, March 17, 2022 / Notices 

ANNUALIZED BURDEN HOUR TABLE—Continued 

Forms 

(if necessary) 

Respondents 

(if necessary) 

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total 

burden hours 

Unit Activity Reporting ...................... MRC Unit Leader ............................. 748 4 15/60 748 

Total ........................................... ........................................................... ........................ 10 ........................ 2,244 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2022–05612 Filed 3–16–22; 8:45 am] 

BILLING CODE 4150–47–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Findings of research 

misconduct have been made against 

Shuo Chen, Ph.D. (Respondent), 

formerly a postdoctoral researcher, 

Department of Physics, University of 

California, Berkeley (UCB). Respondent 

engaged in research misconduct in 

research reported in a grant application 

submitted for U.S. Public Health Service 

(PHS) funds, specifically National 

Institute of Neurological Disorders and 

Stroke (NINDS), National Institutes of 

Health (NIH), grant application K99 

NS116562–01. The administrative 

actions, including supervision for a 

period of one (1) year, were 

implemented beginning on February 28, 

2022, and are detailed below. 

FOR FURTHER INFORMATION CONTACT: 

Wanda K. Jones, Dr.P.H., Acting 

Director, Office of Research Integrity, 

1101 Wootton Parkway, Suite 240, 

Rockville, MD 20852, (240) 453–8200. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that the Office of Research 

Integrity (ORI) has taken final action in 

the following case: 

Shuo Chen, Ph.D., University of 

California, Berkeley: Based on the report 

of an investigation conducted by UCB 

and additional analysis conducted by 

ORI in its oversight review, ORI found 

that Dr. Shuo Chen, formerly a 

postdoctoral researcher, Department of 

Physics, UCB, engaged in research 

misconduct in research reported in a 

grant application submitted for PHS 

funds, specifically NINDS, NIH, grant 

application K99 NS116562–01. 

ORI found that Respondent engaged 

in research misconduct by intentionally, 

knowingly, and/or recklessly falsifying 

data and methods by altering, reusing, 

and relabeling source two-photon 

microscopy and electrophysiological 

data to represent images of mouse 

hippocampal neurons in the following 

grant application: 

• K99 NS116562–01, ‘‘Investigation 

into network dynamics of hippocampal 

replay sequences by ultrafast voltage 

imaging,’’ submitted to NINDS, NIH, on 

June 25, 2019. 

ORI found that Respondent 

intentionally, knowingly, and/or 

recklessly falsified two-photon 

microscopy and in vivo 

electrophysiological activity images, 

figure legends, and text descriptions of 

hippocampal neurons from a mouse 

running on a treadmill in a head-fixed 

virtual reality (VR) set up. Specifically: 

• Respondent reused an image of 

visual cortex neurons to represent 

fluorescence calcium imaging of 

hippocampal neurons in Figure 6d and 

its associated text and figure legend of 

K99 NS116562–01. 

• Respondent reused in vivo 

electrophysiological data from control 

mice of spatial receptive fields for all 

recorded place cells during linear track 

exploration sessions from Supplemental 

Figure 1b from Nat Neurosci. 2018 

Jul;21(7):996–1003 (doi: 10.1038/ 

s41593–018–0163–8) to represent 

several sessions of two-photon 

hippocampal calcium imaging of 

progressive place fields, obtained from 

multiple mice running on a treadmill in 

a head-fixed VR set up, in Figure 6e and 

its associated text and figure legend of 

K99 NS116562–01. 

Respondent neither admits nor denies 

ORI’s findings of research misconduct. 

The parties entered into a Voluntary 

Settlement Agreement (Agreement) to 

conclude this matter without further 

expenditure of time, finances, or other 

resources. The settlement is not an 

admission of liability on the part of the 

Respondent. 

Respondent voluntarily agreed to the 

following: 

(1) Respondent will have his research 

supervised for a period of one (1) year 

beginning on February 28, 2022 (the 

‘‘Supervision Period’’). Prior to the 

submission of an application for PHS 

support for a research project on which 

Respondent’s participation is proposed 

and prior to Respondent’s participation 

in any capacity in PHS-supported 

research, Respondent will submit a plan 

for supervision of Respondent’s duties 

to ORI for approval. The supervision 

plan must be designed to ensure the 

integrity of Respondent’s research. 

Respondent will not participate in any 

PHS-supported research until such a 

supervision plan is approved by ORI. 

Respondent will comply with the 

agreed-upon supervision plan. 

(2) The requirements for Respondent’s 

supervision plan are as follows: 

i. A committee of 2–3 senior faculty 

members at the institution who are 

familiar with Respondent’s field of 

research, but not including 

Respondent’s supervisor or 

collaborators, will provide oversight and 

guidance during the Supervision Period. 

The committee will review primary data 

from Respondent’s laboratory on a 

quarterly basis and submit a report to 

ORI at six (6) month intervals setting 

forth the committee meeting dates and 

Respondent’s compliance with 

appropriate research standards and 

confirming the integrity of Respondent’s 

research. 

ii. The committee will conduct an 

advance review of each application for 

PHS funds, or report, manuscript, or 

abstract involving PHS-supported 

research in which Respondent is 

involved. The review will include a 

discussion with Respondent of the 

primary data represented in those 

documents and will include a 

certification to ORI that the data 

presented in the proposed application, 

report, manuscript, or abstract is 

supported by the research record. 

(3) During the Supervision Period, 

Respondent will ensure that any 

institution employing him submits, in 

conjunction with each application for 

PHS funds, or report, manuscript, or 

abstract involving PHS-supported 

research in which Respondent is 

involved, a certification to ORI that the 

data provided by Respondent are based 

on actual experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported in the application, 

report, manuscript, or abstract. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 52 / Thursday, March 17, 2022 / Notices 15257 

(4) If no supervision plan is provided 

to ORI, Respondent will provide 

certification to ORI at the conclusion of 

the Supervision Period that his 

participation was not proposed on a 

research project for which an 

application for PHS support was 

submitted and that he has not 

participated in any capacity in PHSsupported research. 

(5) During the Supervision Period, 

Respondent will exclude himself 

voluntarily from serving in any advisory 

or consultant capacity to PHS including, 

but not limited to, service on any PHS 

advisory committee, board, and/or peer 

review committee. 

Dated: March 14, 2022. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity, 

Office of the Assistant Secretary for Health. 

[FR Doc. 2022–05659 Filed 3–16–22; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; National Cancer Institute 

(NCI) Generic Clearance for 

Application Information From Fellows, 

Interns, and Trainees 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI) will 

publish periodic summaries of propose 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Diane Kreinbrink, Program 

Manager, Office of Management Policy 

and Compliance, National Cancer 

Institute, 9609 Medical Center Drive, 

Room 1W706, Bethesda, Maryland, 

20892 or call non-toll-free number (240) 

276–7283 or email your request, 

including your address to: 

diane.kreinbrink@nih.gov. Formal 

requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: Generic 

Clearance for Application Information 

from Fellows, Interns, and Trainees, 

0925–0761, Expiration Date 07/31/2022, 

EXTENSION, National Cancer Institute 

(NCI), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The ‘‘Generic Clearance for 

Application Information from Fellows, 

Interns, and Trainees’’ request supports 

research experiences for high school, 

post-baccalaureate (including post 

masters) individuals, graduate students, 

and postdoctoral fellows, interns, and 

trainees in a multidisciplinary 

environment at the NCI. This 

information collection request is for 

applications, reference letters, letters of 

intent and interest, and other related 

documentation necessary for various 

Divisions, Offices, and Centers at NCI to 

evaluate the eligibility, merits, and 

quality of potential candidates. The 

applications will also assist in matching 

potential candidates to various training 

and internship programs. The 

information is for internal use to make 

decisions about candidates invited to 

visit and attend NCI fellowships, 

internships, and other training 

opportunities. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

7,500 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Category of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

time per 

response 

(in hours) 

Total annual 

burden hours 

Individuals (Applicants) .................................................................................... 3,000 1 60/60 3,000

Individuals (Reference Letters) ........................................................................ 9,000 1 30/60 4,500 

Totals ........................................................................................................ ........................ 12,000 ........................ 7,500 

Dated: March 14, 2022. 

Diane Kreinbrink, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2022–05663 Filed 3–16–22; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES